Blog

Aug 30, 2024, 16:29

Julie Gralow: Dr. Debra Patt discusses newly released ASCO Guiding Principles for Responsible Use of AI

Julie Gralow, Chief Medical Officer,

“American Society of Clinical Oncology (ASCO) Board Member and Chair of ASCO’s AI Task Force, Dr. Debra Patt, discusses newly released ASCO Guiding Principles for Responsible Use of AI.”

Quote from Debra A. Patt, MD, PhD, MBA, FASCO

Additional info

Source: Julie Gralow/Linkedin

Julie Gralow is the Chief Medical Officer (CMO) of the American Society of Clinical Oncology (ASCO). Previously, she was the Jill Bennett Endowed Professor of Breast Cancer at the University of Washington School of Medicine, Professor in the Clinical Research Division of the Fred Hutchinson Cancer Research Center, as well as Director of Breast Medical Oncology at the Seattle Cancer Care Alliance. She is the founder of the Women’s Empowerment Cancer Advocacy Network (WE CAN)

American Society for Clinical Oncology (ASCO) artifical intelligence Artificial Intelligence in Oncology ASCO cancer Debra Patt Julie Gralow OncoDaily Oncology

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

Monica Bertagnolli is ending her tenure as NIH director

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

Special Coverage